(L to R): Members of the U.S. Neurology Internal Engine Stephanie Hunter-Banks, Jim Hlavenka, Brad Chapman, Trenton Merideth, Tonja Pitts

UCB’s U.S. Neurology team won a 2019 EyeForPharma award last night in the “Most Promising Agile Transformation” category, which recognizes an experimental initiative that has the potential to disrupt the status quo. The award was presented for the team’s Internal Engine transformation, fulfilling the award criteria of showing agility through rapid creation of a service that touched real customers before being refined and assessed through smart measurement.

At UCB, our approach to innovation is designed around the patient and their individual experience. Every day, Chris Protos, Solution Enablement Lead, wakes up and thinks about ways we can continue to keep patients at the heart of everything we do. Hear more from Chris about how we’re addressing gaps in patient care through our patient-driven approach to innovation by watching the video below.

UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting

As UCB attends the 2019 American Epilepsy Society meeting in Baltimore, Maryland this week, Mike Davis, Head of Neurology in the U.S., talks about the long way to go in managing epilepsy, and how UCB is committed to closing this gap by bringing new solutions to market. Read the article on LinkedIn.

Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira®

• 14 scientific presentations will cover UCB’s pipeline assets, epilepsy-specific research, and licensed medicines, including NAYZILAM, now available for the acute treatment of seizure clusters in epilepsy patients 12 years of age and older
• Friday evening symposium on “Epilepsy Treatment Update for Patients Suffering from Seizure Clusters” includes Epilepsy Foundation’s project on seizure emergencies and a panel discussion on the misconceptions around seizure clusters

At just one day old, Spencer, born in Greenville, South Carolina, had his first seizure, a sudden, uncontrolled electrical disturbance in the brain that usually causes a change in behavior.^1,2